Outset Medical, Inc. (OM)
Market Cap | 779.05M |
Revenue (ttm) | 110.24M |
Net Income (ttm) | -138.80M |
Shares Out | 47.79M |
EPS (ttm) | -2.97 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,071,372 |
Open | 15.55 |
Previous Close | 15.46 |
Day's Range | 15.26 - 16.31 |
52-Week Range | 13.25 - 60.33 |
Beta | n/a |
Analysts | Buy |
Price Target | 37.33 (+129.0%) |
Earnings Date | Aug 4, 2022 |
About OM
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. [Read more...]
Financial Performance
In 2021, Outset Medical's revenue was $102.60 million, an increase of 105.47% compared to the previous year's $49.94 million. Losses were -$131.94 million, 66.3% more than in 2020.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for OM stock is "Buy." The 12-month stock price forecast is 37.33, which is an increase of 129.02% from the latest price.
News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Outset Medical, Inc. - OM
New York, New York--(Newsfile Corp. - June 25, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or the "Company") (NASDAQ: OM). Such investors are a...
3 Medical Info System Stocks Braving Industry Headwinds
Medical Info Systems stocks like Omnicell, Inc. (OMCL), Axonics, Inc. (AXNX) and Outset Medical, Inc. (OM) are expected to gain despite pandemic-led disruptions.
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $100,00...
Los Angeles, California--(Newsfile Corp. - June 18, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset...
OUTSET ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Outset Stockholders and ...
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Outset Medical, Inc. (“Outset” or the “Co...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors With Losses to Inquire About Securities...
NEW YORK , June 16, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Outset Medical, Inc. (N...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Outset Medical, Inc....
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Outset Medical, Inc. (“Outset” or the “Company...
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of ...
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) investors concerning the Company's p...
The Law Offices of Frank R. Cruz Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) on behalf of investors concerning the Company'...
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Outset Medical, Inc. with Losses of $100,000 to Con...
Los Angeles, California--(Newsfile Corp. - June 15, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outse...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Outset Medical, Inc. (OM...
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Outset Medical, Inc...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Outset Medical, Inc. (OM) on Behalf of Inve...
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) investors concerning the Company's po...
Outset Medical Plunges on Shipment Hold: Buy the Stock on the Sell-Off?
The temporary issue could present a great buying opportunity for long-term investors.
The Law Offices of Frank R. Cruz Announces Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Outset Medical, Inc. (“Outset” or the “Company”) (NASDAQ: OM) on behalf of investors concerning the Company's...
OM INVESTOR NOTICE: Rosen Law Firm Encourages Outset Medical, Inc. Investors with Losses to Inquire About Securities ...
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Outset Medical, Inc. (NASDAQ: OM...
Why Outset Medical Shares Are Trading Lower Today
Outset Medical Inc (NASDAQ: OM) implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the FDA review and clearance of a 510(k). The company submitted for ...
Outset Medical Announces Shipment Hold on New Tablo Systems for Home Use Pending FDA Review and Clearance of Recent 5...
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “company”) today announced it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System f...
Outset Medical to Present at Upcoming Investor Conferences
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
2 No-Brainer Stocks to Buy Right Now for Less than $55
These companies have low share prices and high potential.
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -1.52% and 0.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Outset Medical Reports First Quarter 2022 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity...
3 Healthcare Companies With Revenue Spiking 100% or More
Here's why three Fool.com contributors are bullish on Outset Medical, Aurinia Pharmaceuticals, and Shockwave Medical.
Analysts Estimate Outset Medical, Inc. (OM) to Report a Decline in Earnings: What to Look Out for
Outset Medical, Inc. (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why I'm Over the Moon for This Healthcare Stock -- In One Chart
This company helps keep patients at home with dialysis treatments.
Outset Medical to Present at the BofA Securities 2022 Healthcare Conference
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, tod...
Outset Medical Names Business Leader Dale E. Jones to Board of Directors
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis, today announced the appointment of Dale E. Jon...